Lantern Pharma develops cancer drugs using an artificial intelligence platform to match them with suitable patients. LTRN reports earnings on Wed, Nov 11, 2026.
Earnings
Earnings calendar →Seasonality
How LTRN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.
Whale Options Flow
90DNo whale options trades in LTRN in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LTRN is in one of them and how their past LTRN trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered LTRN in an article yet. Here's the latest on the wider market.
About Lantern Pharma
Lantern Pharma is a Dallas, Texas company that develops cancer drugs. It uses an artificial intelligence platform, called RADR, to analyze large sets of medical and research data and to identify the patients most likely to respond to each drug. Its pipeline includes several small molecule candidates in clinical trials for solid tumors and blood cancers, and it also works on reviving older compounds that were previously halted. The company plans to offer some of its AI tools to other researchers and drug developers.
- Headquarters
- Dallas, TX